Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India

View source ↗

Summary

A completed clinical trial in India evaluating how oral semaglutide works in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rybelsus (oral semaglutide) (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED